Loading stock…

Olympus Corporation (7733) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Olympus Corporation

7733Market cap $13BPrice $12.6

Country🇯🇵Japan

SectorHealthcare

IndustryHealthcare Equipment

Makes the endoscopes doctors use to see inside your body without cutting you open. Olympus controls roughly 70% of the global market for gastrointestinal endoscopes, making it the quiet gatekeeper of modern non-invasive diagnostics worldwide.

In Bastion Portfolios?

52W Return+5%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-1%2

Revenue Forecast

Rev CAGR (1y)+23%8

Rev CAGR (3y)+5%4

Rev CAGR (5y)+5%4

Earnings Forecast

EPS Growth Y+1+16%8

EPS Growth Y+2+13%7

EPS Growth Y+3+12%7

Quality

Margins

EBIT Margin14%6

Net Income Margin7%5

Free Cash Flow Margin7%5

Debt

Net Debt/EBITDA0.96

Efficiency

ROE11%5

ROA5%6

Earnings Stability55

GEAR+AVERAGE40

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)233

P/E Ratio (Forward 3y)222

P/BV2.85

EV Multiples

EV/EBITDA Fwd106

EV/EBIT Fwd146

Yield

Free Cash Flow Yield3.4%5

Dividend Yieldna–

Momentum

Short term

1 month return+2%8

3 month return+13%9

YTD return+3%5

Mid term

Price vs 52wHigh90%8

1 year return+9%6

Long term

3 year return+7%3

5 year return-10%3

Risk Shield

Price Risk

Beta0.58

Volatility42%4

Free Cash Flow

Free Cash Flow Margin7%5

Free Cash Flow Yield3.4%5

Quality

ROCE14%7

Earnings Stability55

Net Debt/EBITDA0.96

02Growth

Is it actually growing, and how fast?

7733Olympus

Revenue FY26$6.4B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-1%2

Revenue, next 1Y+23%8

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+16%8

EPS growth, FY28E+13%7

EPS growth, FY29E+12%7

GROWTH ASSESSMENT

STRENGTHS

After shrinking over the last 3 years, revenue is set to grow 5%/yr from here.

Earnings are set to grow faster than sales (EPS about 13%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Revenue fell 1%/yr over the last 3 years, behind 80% of companies worldwide.2/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE64 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+13%9

YTD return+3%5

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+9%6

3-year return+7%3

5-year return-10%3

MOMENTUM ASSESSMENT

STRENGTHS

It's up 9% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+13%).

WATCH

Returns sit at the market level so far this year (+3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+7.1% over three years and -9.7% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Olympus. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

7733Olympus

Revenue FY26$6.4B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-1%2

Revenue, next 1Y+23%8

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+16%8

EPS growth, FY28E+13%7

EPS growth, FY29E+12%7

GROWTH ASSESSMENT

STRENGTHS

After shrinking over the last 3 years, revenue is set to grow 5%/yr from here.

Earnings are set to grow faster than sales (EPS about 13%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, in line with the market.5/10

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Revenue fell 1%/yr over the last 3 years, behind 80% of companies worldwide.2/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE64 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+13%9

YTD return+3%5

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+9%6

3-year return+7%3

5-year return-10%3

MOMENTUM ASSESSMENT

STRENGTHS

It's up 9% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+13%).

WATCH

Returns sit at the market level so far this year (+3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+7.1% over three years and -9.7% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Olympus. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community